These 2 Stocks Are Growing at +30% Despite the Potential Recession

Recession-resistant growth stocks like Dollarama (TSX:DOL) are still growing faster than 30%.

| More on:
A stock price graph showing growth over time

Image source: Getty Images.

Investors are seeking safety as inflation and recession loom on the horizon. Energy and bank stocks are popular in this environment, while growth stocks are clearly out of favour. However, some growth stocks are sustaining their pace of expansion, despite the economic downturn. 

These companies are part of a secular growth wave. That means their market opportunity is detached from the rest of the economy and isn’t subject to the same market cycle. For long-term investors, these are ideal targets. Here are the top two growth stocks that have delivered 30% or more in earning expansion in recent quarters. 

Dollarama

Discount retailers have been steadily consuming market share for years. After all, who doesn’t like a bargain? That’s probably why Dollarama (TSX:DOL) stock is up 2,300% since 2009. That’s a compound annual growth rate (CAGR) of 27.3% over 13 years. 

This year, sales are expanding even faster. In its most recent quarter, Dollarama’s revenue expanded by 18.2%, while operating income surged 30.3% year over year. Net diluted income per share was up 37% over the same period. 

Dollarama’s recent growth spurt is fueled by recession and inflation. Canadian families have shifted some of their demand to low-cost retailers, as their finances have been squeezed. In fact, some reports suggest that even relatively wealthy families (earning over $100,000) have been shopping at dollar stores this year. 

Economists expect the next recession to cause severe job losses. Meanwhile, inflation has proven to be more persistent than anticipated. These factors could drive Dollarama’s growth in 2023 and beyond. 

This is why Dollarama is an ideal target for growth investors seeking an attractive, recession-resistant bet in 2022. 

WELL Health Technologies

Virtual healthcare and medical data management is another secular trend. That means patients are visiting virtual clinics and clinics are spending on new technology, despite the economic downturn. This is why WELL Health Technologies (TSX:WELL) has experienced steady growth in 2022. 

In fact, WELL Health has had an incredible year. The acquisition in the U.S. is now being reflected in their quarterly growth numbers. In its most recent quarter, the company’s revenue was up 127% year over year. WELL Health also swung from a net loss last year to a net profit this year on an adjusted basis. 

For the full year, the company expected to generate $550 million in revenue. Meanwhile, the market capitalization is just $749 million. Put simply, the stock is trading at just 1.36 times revenue and is severely undervalued. 

WELL Health’s acquisition-based growth model should be easy to execute this year. Software companies and healthtech startups have seen their valuations plummet. This means WELL Health can acquire them at better prices. Meanwhile, the demand for better healthtech remains as strong as ever. 

Add this recession-resistant growth stock to your watch list. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has positions in WELL Health Technologies Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Bank sign on traditional europe building facade
Bank Stocks

Are Canadian Bank Stocks Still Undervalued?

Bank stock are moving higher. Is it time to buy or wait?

Read more »

You Should Know This
Stocks for Beginners

5 Things to Know About Cargojet Stock in November 2022

Cargojet (TSX:CJT) stock should continue to see massive growth in the near and long term, thanks to long-term agreements and…

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Dividend Stocks

Better Buy: BCE Stock or Enbridge?

BCE and Enbridge pay growing dividends with high yields. Is one more attractive today?

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Investing

TFSA: 3 TSX Stocks to Buy With the New $6,500 Room Limit

Canadians who are eager to utilize the new $6,500 room limit in 2023 should look to TSX stocks like Aritzia…

Read more »

Financial technology concept.
Investing

The Smartest Stocks to Buy With $20 Right Now and Hold Forever

Given the favourable market conditions and their growth initiatives, these three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

2 Unstoppable Dividend Stocks to Load Up in Your TFSA

These two dividend stocks provide long-term passive income that comes out every month, thanks to lease agreements lasting over a…

Read more »

Doctor talking to a patient in the corridor of a hospital.
Tech Stocks

3 Healthcare Stocks to Buy for Long-Term Passive Income

Healthcare stocks provide exposure to an essential service sector. They are also the best for passive income in the short…

Read more »

potted green plant grows up in arrow shape
Investing

4 TSX Growth Stocks to Buy and Hold Forever

Here's why TSX growth stocks, and these four stocks specifically, are some of the best investments you can buy in…

Read more »